Modelling uncertainty in survival and cost-effectiveness is vital in the era of gene therapies: the case of axicabtagene ciloleucel

Publication date: Available online 21 May 2019Source: Health Policy and TechnologyAuthor(s): Adam JN Raymakers, Dean A Regier, Stuart J Peacock

Source: Health Policy and Technology - May 22, 2019 Category: Health Management Source Type: research